Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis
More than half of the ATTR-CA patients have AF, which was associated with wild-type amyloid transthyretin, greater Columbia stage, and increased LAVI. About half of the ATTR-CA individuals developed AF after 2 years, which was predicted by the Columbia score, but not the CHARGE-AF score. ATTRv and tafamidis were protective against incident AF.
Authors
- Jeffeny De Los Santos
- Margaret Cuomo
- Elaine Y. Wan (ORCID: https://orcid.org/0000-0002-5328-7282)
- José Dizon (ORCID: https://orcid.org/0000-0002-1808-9782)
- Yevgeniy Brailovsky (ORCID: https://orcid.org/0000-0002-4811-5267)
- Alfonsina Mirabal
- Nicholas Chan (ORCID: https://orcid.org/0000-0002-8765-7798)
- Stephen Helmke (ORCID: https://orcid.org/0000-0003-2764-3009)
- Samantha Guadalupe
- Hirad Yarmohammadi (ORCID: https://orcid.org/0000-0002-6072-5834)
- Massiel Jimenez
- Dia Smiley
- Angelo Biviano
- Ariel Y. Weinsaft
- Sergio Teruya
- Mathew S. Maurer
Institutions
- NewYork–Presbyterian Hospital (US)
- Columbia University Irving Medical Center (US)
- New York Hospital Queens (US)
- Columbia University (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102470
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00